ArticleEuropean journal of clinical pharmacology2024

Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients.

Dabei Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.